Clinical trial
A Randomized, Controlled Trial on Dexmedetomidine for Providing Adequate Sedation and Preserved Neurologic Examination for Endovascular Treatment of Acute Ischemic Stroke or Cerebral Vasospasm.
NCT01845441 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled Trial on Dexmedetomidine for Providing Adequate Sedation and Preserved Neurologic Examination for Endovascular Treatment of Acute Ischemic Stroke or Cerebral Vasospasm.
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- April 30, 2012
- Completion date
- December 31, 2021
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain ischemia, hemorrhage, intracranial, stroke, vasospasm, intracranial